Blood Preparation Market by Products (Whole Blood, Blood Components, and Blood Derivatives), Antithrombotic and Anticoagulants Types (Platelet Aggregation Inhibitors, Fibrinolytics, and Anticoagulants), Antithrombotic and Anticoagulants Applications (Thrombocytosis, Pulmonary Embolism, Renal Impairment, Angina Blood Vessel Complications, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023–2031

Blood Preparation Market Outlook 2031

The global blood preparation market size was valued at USD 45.25 Billion in 2022 and is likely reach to USD 79.08 Billion by 2031, expanding at a CAGR of 6.4% during the forecast period, 2023–2031. The growth of the market is attributed to the growing demand for blood and its components in surgical procedures.

Blood is a fluid that circulates in the human body and contains platelets, plasma, red blood cells, and white blood cells as its main components. It provides nutrients, oxygen, and eliminates waste from the body. Until being transfused, blood is processed and sorted into major components in hospitals. People need blood transfusions for a variety of reasons including surgical operations, diseases infection, or disease treatment, which help to supply the requirement of blood.

Previously, the whole blood was often collected and separated; however, thanks to automated collection, only the blood components needed for transfusion are now collected. Automated blood collection and preparation is becoming more common these days for various applications of blood components transfusion.

Blood Preparation Market Trends, Drivers, Restraints, and Opportunities

• Increasing incidence of road accidents and injuries leading to an increase in surgical procedures and growing awareness of blood donation are expected to fuel the market growth.
• The implementation of new technologies for blood transfusion as well as the growing use of plasma and platelet transfusion in the pharmaceutical industry are expected to contribute the market growth.
• Various governments’ policies around the world encouraging to increase blood donation rates by implementing reimbursement policies as well as monetary benefits for donors are expected to propel the global market expansion.
• Existing some degree of problems associated with unsafe handling of blood and blood products are key challenges that can hamper the market growth.
• Technological advancement that helps in the development of new techniques for blood preparation by maintaining a safe storage of bloods are creating major opportunities for the market players.

Scope of Blood Preparation Market Report

The report on the global blood preparation market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes	Details
Report Title	Blood Preparation Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
Base Year	2022
Historic Data	2016–2021
Forecast Period	2023–2031
Segmentation	Products (Whole Blood, Blood Components, and Blood Derivatives), Antithrombotic and Anticoagulants Types (Platelet Aggregation Inhibitors, Fibrinolytics, and Anticoagulants), and Antithrombotic and Anticoagulants Applications (Thrombocytosis, Pulmonary Embolism, Renal Impairment, Angina Blood Vessel Complications, and Others)
Regional Scope	Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
Report Coverage	Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered in the Report	AstraZeneca PLC; Sanofi S.A.; LEO Pharma A/S; Bristol-Myers Squibb Company; Baxter International, Inc.; Pfizer, Inc.; Portola Pharmaceuticals, Inc.; and GlaxoSmithKline PLC

Blood Preparation Market Segment Insights

Whole blood segment to account for a key market share

Based on products, the global blood preparation market is segmented into whole blood, blood derivatives, and blood components. The whole blood segment is projected to account for a key market share during the forecast period owing to the growing demand for whole blood for major surgeries and transfusions as well as its certain benefits such as ease of availability, low cost, and maintenance.

Meanwhile, the blood derivatives segment is expected to expand at a fast CAGR during the forecasted period. Government programs to produce plasma-derived proteins including immunoglobulins, coagulation factor products, human fibrin foam, dried human plasma, and human thrombin are expected to fuel the segment growth.

In cases of life-threatening infections including Ebola, blood derivatives such as intravenous immunoglobulin and hyperimmune are used to improve and enhance the immunity. The rising prevalence of such diseases, the implementation of advanced technology to isolate the components, and the introduction of blood-derived medicines are key factors boosting the segment development.

Anticoagulants segment to grow significantly

On the basis of antithrombotic and anticoagulants types, the market is categorized into platelet aggregation inhibitors, fibrinolytic, and anticoagulants. The anticoagulants segment dominated the market in 2020 and is expected to grow significantly during the forecast period.

The growth of the segment is attributed to the development of new products with higher efficacy as well as the potential commercialization of new products currently in the process. Biopharmaceutical companies are updating their products by bringing to market new and more effective anticoagulant drugs.

Moreover, the re-launch of some key drug products, such as Urokinase in North America, is expected to fuel the segment development. Heparins, vitamin K antagonists, direct thrombin inhibitors, and direct factor Xa inhibitors are all anticoagulant medications widely adopted for numerous applications.

Thrombocytosis segment to holds a key market share

Based on antithrombotic and anticoagulants applications, the global blood preparation market is segmented into thrombocytosis, pulmonary embolism, renal impairment, angina blood vessel complications, and others.

The thrombocytosis segment is expected to hold a key share of the market during the forecast period owing to wide use of thrombocytosis and antithrombotic products. A higher platelet count allows blood to coagulate in the circulatory system, resulting in life-threatening heart conditions.

There are two types of thrombocytosis: primary and secondary. Primary thrombocytosis is an uncommon disease that affects about 24 people per million worldwide. It is more common in middle-aged people and women under the age of 40. Hyposplenism, splenectomy, asplenia, hemorrhage, osteosarcoma, and rheumatoid arthritis are common types of disorders that cause secondary thrombocytosis.

The angina blood vessel complications segment is expected to grow significantly during the forecast period due to rising R&D for the production of anticoagulants for cardiac problems and growing prevalence of cardiovascular disorders (CVDs).

Although nitroglycerine is the main treatment for angina, anticoagulants is often used due to the low risk and less complications as compared to the former.

Furthermore, the segment growth is due to factors such as an increase in lifestyle-related diseases, the prevalence of oral anticoagulants, increasing patient awareness, increased healthcare spending, and favorable government policies.

Blood Preparation Market Regional Outlook

North America dominated the market with a large revenue share

In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America held a dominant share of the market with a large revenue share in 2020 and is expected to constitute a major share of the market during the forecast period due to the high incidence of CVDs, leukemia, and hematological and neurological diseases.

Higher levels of patient awareness and healthcare spending as well as advanced healthcare facilities especially in the US are expected to grow the regional market at a rapid pace. On the other hand, the market in Asia Pacific is expected to grow at a significant rate during the forecast period owing to the presence of untapped opportunities, economic development, and rising initiatives by private and public organizations.

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Blood Preparation Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Blood Preparation Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Blood Preparation Market - Supply Chain
  4.5. Global Blood Preparation Market Forecast
     4.5.1. Blood Preparation Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Blood Preparation Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Blood Preparation Market Absolute $ Opportunity
5. Global Blood Preparation Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Blood Preparation Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Blood Preparation Demand Share Forecast, 2019-2026
6. North America Blood Preparation Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Blood Preparation Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Blood Preparation Demand Share Forecast, 2019-2026
7. Latin America Blood Preparation Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Blood Preparation Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Blood Preparation Demand Share Forecast, 2019-2026
8. Europe Blood Preparation Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Blood Preparation Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Blood Preparation Demand Share Forecast, 2019-2026
9. Asia Pacific Blood Preparation Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Blood Preparation Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Blood Preparation Demand Share Forecast, 2019-2026
10. Middle East & Africa Blood Preparation Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Blood Preparation Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Blood Preparation Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Blood Preparation Market: Market Share Analysis
  11.2. Blood Preparation Distributors and Customers
  11.3. Blood Preparation Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. AstraZeneca PLC
     11.4.2. Sanofi S.A.
     11.4.3. LEO Pharma A/S
     11.4.4. Bristol-Myers Squibb Company
     11.4.5. Baxter International, Inc.
     11.4.6. Pfizer, Inc.
     11.4.7. Portola Pharmaceuticals, Inc.
     11.4.8. GlaxoSmithKline PLC